An analysis by Mergermarket, an Acuris company, reveals the top U.S. cities for healthcare M&A.
The other, smaller (cell) lung cancer
March 18th 2024Small cell lung cancer is a less common form of lung cancer and very aggressive. Researchers and drug developers are looking for new treatments, especially for patients whose cancers have stopped responding to first- and second-line treatments. Tarlatamab, a bispecific T-cell engager, looks promising as a third-line treatment.
Read More
A Deep Dive into Predictive and Generative AI with Lynn Carroll of HSBlox
January 3rd 2024In this month’s episode, Briana Contreras, an editor of MHE, chatted with Lynn Carroll, executive of HSBlox, about the difference between predictive and generative AI, yet how each works together in preventive healthcare.
Listen